1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Body Weight in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higgins, LA; Kim, KH; Kim, SH; Li, L; Liao, JD; Lu, J; Nkhata, K; Shaik, AA; Wang, L; Xing, C; Zhang, J; Zhang, Y | 1 |
Halemani, PD; Mohan, CG; Rajendra, CE; Savinay, G; Viswanatha, GL | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Body Weight
Article | Year |
---|---|
Mouse prostate proteome changes induced by oral pentagalloylglucose treatment suggest targets for cancer chemoprevention.
Topics: Administration, Oral; Animals; Biomarkers; Blotting, Western; Body Weight; Hydrolyzable Tannins; Male; Maximum Tolerated Dose; Mice; Mice, Inbred C57BL; Organ Size; Prostate; Prostatic Neoplasms; Proteome; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |
1,2,3,4,6 Penta-O-galloyl-β-d-glucose, a bioactivity guided isolated compound from Mangifera indica inhibits 11β-HSD-1 and ameliorates high fat diet-induced diabetes in C57BL/6 mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue, White; Animals; Body Weight; Carbenoxolone; Corticosterone; Diabetes Mellitus, Experimental; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glucose Tolerance Test; Hydrolyzable Tannins; Hypoglycemic Agents; Insulin; Liver; Male; Mangifera; Mice; Mice, Inbred C57BL; Phytotherapy; Plant Leaves | 2013 |